Reimbursed Care Access in Uzbekistan

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. National lists and decrees governing narcotics and psychotropic substances restrict circulation of non‑authorized hallucinogens, and unlawful possession/trafficking is subject to penalties under the Criminal Code of the Republic of Uzbekistan # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Possession, production, or trafficking may trigger criminal penalties and regulatory enforcement under Uzbekistan’s narcotics and psychotropic substance control framework. See national controlled‑substances lists and the Criminal Code for penalties. # #.

No publicly available evidence of esketamine (Spravato) registration, marketing authorization, or inclusion on Uzbekistan public reimbursement lists as of the available national sources; therefore esketamine is not known to be an approved or reimbursed therapy in Uzbekistan. Medical use of related anesthetic agents is tightly regulated and substances containing narcotic/psychotropic components are subject to strict accounting and prescription rules under Cabinet of Ministers decrees and Ministry of Health regulation # #. (No Uzbekistan Ministry of Health public register entry or authoritative national reimbursement listing for esketamine was identified in the cited national sources.)

Ketamine is listed among psychotropic substances whose circulation is limited under Uzbekistan’s Decree of the Cabinet of Ministers (List III), and it is permitted for medical/anesthetic use under regulated supply, accounting and prescription controls. The national decree that defines List I–IV (including the list showing ketamine in List III) governs importation, possession, and therapeutic use under state control; medical facilities may use ketamine for anesthesia and other indicated clinical purposes under these controls #.

Regulatory and reimbursement context: Uzbekistan’s regulatory framework treats ketamine as a controlled psychotropic drug requiring strict recordkeeping and limits on circulation; this means ketamine is available for recognized medical indications (primarily anesthesia and other hospital uses) but is not presented in publicly available national documents as a broadly reimbursed outpatient psychiatric treatment. Public reimbursement and coverage of off‑label ketamine infusions for psychiatric conditions (e.g., treatment‑resistant depression) are not evidenced in national reimbursement materials; any use outside established anesthetic/medical indications would be subject to Ministry of Health oversight, facility licensing and narcotics/psychotropic accounting rules # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. DMT and DMT‑containing preparations (e.g., ayahuasca) fall under the national narcotics/psychotropic control regime; unauthorized possession, distribution, or trafficking is a criminal offense under the Criminal Code. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. As a potent tryptamine not authorized by national health authorities for clinical use, 5‑MeO‑DMT is subject to the same narcotics/psychotropic controls and criminal sanctions as other non‑authorized hallucinogens. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no indication in national sources of licensed medical programs or reimbursement for ibogaine; its possession or use outside approved research would fall under criminal narcotics/psychotropic statutes. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Because ayahuasca preparations contain DMT, they are treated under the national narcotics/psychotropic control regime; ritual or religious exemptions are not publicly codified in Uzbekistan national law sources. Unauthorized use, possession or importation is subject to criminal penalties. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and mescaline-containing cacti would be regulated under narcotics/psychotropic provisions; Uzbekistan’s criminal and drug‑control statutes apply to unauthorized possession, cultivation, importation or distribution. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Synthetic phenethylamines in the 2C family are encompassed by Uzbekistan’s controlled‑substance regime; illegal manufacture, possession or distribution is subject to criminal sanction under the Criminal Code and implementing decrees. # #.